Globus Medical Inc Class A GMED
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GMED is a good fit for your portfolio.
News
-
Globus Medical Schedules First Quarter Earnings Release and Conference Call
-
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
-
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
-
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
Trading Information
- Previous Close Price
- $51.79
- Day Range
- $51.10–52.04
- 52-Week Range
- $43.39–62.88
- Bid/Ask
- $45.59 / $56.00
- Market Cap
- $6.93 Bil
- Volume/Avg
- 1.2 Mil / 1.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 22.32
- Price/Sales
- 3.79
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 3.22%
Company Profile
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 5,000
- Website
- https://www.globusmedical.com
Comparables
Valuation
|
Metric
|
GMED
|
NUVA
|
OFIX
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.32 | 19.87 | 584.58 |
Price/Book Value | 1.77 | 2.34 | 0.82 |
Price/Sales | 3.79 | 1.79 | 0.65 |
Price/Cash Flow | 16.49 | 11.86 | 58.69 |
Price/Earnings
GMED
NUVA
OFIX
Financial Strength
|
Metric
|
GMED
|
NUVA
|
OFIX
|
|---|---|---|---|
Quick Ratio | 2.61 | 0.60 | 0.98 |
Current Ratio | 4.88 | 1.25 | 2.54 |
Interest Coverage | — | 2.90 | −16.23 |
Quick Ratio
GMED
NUVA
OFIX
Profitability
|
Metric
|
GMED
|
NUVA
|
OFIX
|
|---|---|---|---|
Return on Assets (Normalized) | 7.89% | 4.87% | −13.57% |
Return on Equity (Normalized) | 9.56% | 12.28% | −19.53% |
Return on Invested Capital (Normalized) | 8.39% | 6.21% | −16.16% |
Return on Assets
GMED
NUVA
OFIX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Tlkpmdvl | Gspdml | $183.8 Bil | |
SYK
| Stryker Corp | Fzpkbppzr | Hjkf | $127.8 Bil | |
MDT
| Medtronic PLC | Vplrmcpwn | Jgcftg | $105.0 Bil | |
BSX
| Boston Scientific Corp | Vsfjkyd | Cbyxgp | $99.9 Bil | |
EW
| Edwards Lifesciences Corp | Nkxysptq | Pzzdchh | $52.5 Bil | |
DXCM
| DexCom Inc | Lccmbmjt | Cthpn | $51.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Wqllbjcb | Mjyn | $24.9 Bil | |
ALGN
| Align Technology Inc | Rbvpdmffd | Bkvxcn | $22.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Gcwlxgbdm | Fmwvsxf | $18.5 Bil | |
PODD
| Insulet Corp | Fjcnhsnmxy | Pzwhs | $11.6 Bil |